Electron Canon Purifies Indoor Environments
By HospiMedica International staff writers Posted on 04 May 2021 |
Image: The Shycocan device emits an electron stream to disrupt virus transmission (Photo courtesy of SSTx)
A novel virus deactivation system uses an extremely high-intensity discharge of electrons to actively impede air and surface transmission of the Corona family of viruses.
The Shreis Scalene Therapeutics (SSTx; Gaithersburg, MD, USA) scalene hypercharge corona canon (Shycocan) uses proprietary photon-mediated electron emitters (PMEEs) to discharge trillions of electrons every second. The intense kinetic energy impedes the negative-charge seeking mechanism of the SARS-CoV-2 spike protein, actively disarming air and surface transmission. Shycocan does not use any chemicals, and does not produce ozone, reactive oxygen species (ROS), oxides of nitrogen, or other harmful compounds.
The technology is based on a super alloy, scalene, that release the hypercharged electrons. The plug and play device requires no setup, except for mounting on side wall, pedestal, or table-top, and access to a power outlet. Once turned on, Shycocan begins working instantaneously. The device can be deployed in all environments, and does not interfere with other electronic devices such as air conditioning or cellular communications. It is also being studied for use in farms to prevent the transmission of the G4-EA-H1N1 virus, described as being highly adapted to infect humans.
“No ultraviolet light, filter-systems, hazardous ozone, or other harmful chemical emission occurs with the Shycocan,” said Professor Meena Augustus PhD, founder, president, CEO, and CSO of SSTx. “A salient feature of this technology, that has also been biologically validated, is that while viruses are targeted, beneficial bacteria, fungi or other micro-organisms, human and mammalian epithelial cells are not, making it eco-, people, and pet friendly.”
Related Links:
Shreis Scalene Therapeutics
The Shreis Scalene Therapeutics (SSTx; Gaithersburg, MD, USA) scalene hypercharge corona canon (Shycocan) uses proprietary photon-mediated electron emitters (PMEEs) to discharge trillions of electrons every second. The intense kinetic energy impedes the negative-charge seeking mechanism of the SARS-CoV-2 spike protein, actively disarming air and surface transmission. Shycocan does not use any chemicals, and does not produce ozone, reactive oxygen species (ROS), oxides of nitrogen, or other harmful compounds.
The technology is based on a super alloy, scalene, that release the hypercharged electrons. The plug and play device requires no setup, except for mounting on side wall, pedestal, or table-top, and access to a power outlet. Once turned on, Shycocan begins working instantaneously. The device can be deployed in all environments, and does not interfere with other electronic devices such as air conditioning or cellular communications. It is also being studied for use in farms to prevent the transmission of the G4-EA-H1N1 virus, described as being highly adapted to infect humans.
“No ultraviolet light, filter-systems, hazardous ozone, or other harmful chemical emission occurs with the Shycocan,” said Professor Meena Augustus PhD, founder, president, CEO, and CSO of SSTx. “A salient feature of this technology, that has also been biologically validated, is that while viruses are targeted, beneficial bacteria, fungi or other micro-organisms, human and mammalian epithelial cells are not, making it eco-, people, and pet friendly.”
Related Links:
Shreis Scalene Therapeutics
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration